SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-018603
Filing Date
2023-11-09
Accepted
2023-11-09 16:30:51
Documents
66
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q agrx-20230930x10q.htm   iXBRL 10-Q 1587930
2 EX-10.2 agrx-20230930xex10d2.htm EX-10.2 139266
3 EX-31.1 agrx-20230930xex31d1.htm EX-31.1 10624
4 EX-31.2 agrx-20230930xex31d2.htm EX-31.2 10566
5 EX-32.1 agrx-20230930xex32d1.htm EX-32.1 5943
6 EX-32.2 agrx-20230930xex32d2.htm EX-32.2 5909
  Complete submission text file 0001558370-23-018603.txt   6502638

Data Files

Seq Description Document Type Size
7 EX-101.SCH agrx-20230930.xsd EX-101.SCH 48263
8 EX-101.CAL agrx-20230930_cal.xml EX-101.CAL 44707
9 EX-101.DEF agrx-20230930_def.xml EX-101.DEF 191739
10 EX-101.LAB agrx-20230930_lab.xml EX-101.LAB 416997
11 EX-101.PRE agrx-20230930_pre.xml EX-101.PRE 304971
60 EXTRACTED XBRL INSTANCE DOCUMENT agrx-20230930x10q_htm.xml XML 943904
Mailing Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635
Business Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635 609-683-1880
AGILE THERAPEUTICS INC (Filer) CIK: 0001261249 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36464 | Film No.: 231393087
SIC: 2834 Pharmaceutical Preparations